Literature DB >> 15878541

Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003.

E Faglia1, L Dalla Paola, G Clerici, J Clerissi, L Graziani, M Fusaro, L Gabrielli, S Losa, A Stella, M Gargiulo, M Mantero, M Caminiti, S Ninkovic, V Curci, A Morabito.   

Abstract

OBJECTIVE: To evaluate the effectiveness of peripheral angioplasty (PTA) as the first-choice revascularisation procedure in diabetic patients with critical limb ischemia (CLI).
DESIGN: Prospective study.
METHODS: PTA was employed as first choice revascularisation in a consecutive series of diabetic patients hospitalized for CLI between January 1999 and December 2003.
RESULTS: PTA was successful performed in 993 patients. Seventeen (1.7%) major amputations were carried out. One death and 33 non-fatal complications were observed. Mean follow-up was 26+/-15 months. Clinical restenosis was observed in 87 patients. The 5 years primary patency was 88%, 95% CI 86-91%. During follow-up 119 (12.0%) patients died at a rate of 6.7% per year.
CONCLUSIONS: PTA as the first choice revascularisation procedure is feasible, safe and effective for limb salvage in a high percentage of diabetic patients. Clinical restenosis was an infrequent event and PTA could successfully be repeated in most cases.

Entities:  

Mesh:

Year:  2005        PMID: 15878541     DOI: 10.1016/j.ejvs.2005.02.035

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  39 in total

1.  A solution to ankle-brachial index limitations in peripheral transluminal angioplasty.

Authors:  Manuel Pardo; Miguel Alcaraz; Fernando Luis Bernal; Jose Manuel Felices; Gyingriri Daniel Achel; Francisco Ramon Breijo-Marquez; Manuel Canteras
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

Review 2.  [Recanalization of the lower leg: PTA or stent?].

Authors:  S Müller-Hülsbeck
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

3.  [S3 guidelines for diagnostics and treatment of peripheral arterial occlusive disease].

Authors:  P Huppert; J Tacke; H Lawall
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

4.  The assessment of Buerger's exercise on dorsal foot skin circulation in patients with vasculopathic diabetic foot ulcer by using wireless near-infrared spectroscope: a cohort prospective study.

Authors:  Bor-Shyh Lin; Chang-Cheng Chang; Chun-Lin Su; Jhe-Ruei Li; Min-Ling Chen; Mei-Yen Chen; Yao-Kuang Huang
Journal:  Lasers Med Sci       Date:  2018-01-08       Impact factor: 3.161

Review 5.  Treating calf and pedal vessel disease: the extremes of intervention.

Authors:  Marco Manzi; Luis M Palena
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

Review 6.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

Review 7.  Diagnostics and treatment of the diabetic foot.

Authors:  Jan Apelqvist
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

8.  Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic.

Authors:  Luigi Uccioli; Roberto Gandini; Laura Giurato; Sebastiano Fabiano; Enrico Pampana; Vincenza Spallone; Erika Vainieri; Giovanni Simonetti
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

9.  [Diabetic foot syndrome from the perspective of angiology and diabetology].

Authors:  H Lawall; C Diehm
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

10.  Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study.

Authors:  Ezio Faglia; Giacomo Clerici; Jacques Clerissi; Livio Gabrielli; Sergio Losa; Manuela Mantero; Maurizio Caminiti; Vincenzo Curci; Antonella Quarantiello; Tommaso Lupattelli; Tommaso Luppattelli; Alberto Morabito
Journal:  Diabetes Care       Date:  2009-02-17       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.